From the beginning, it has been clear that the State Health Plan (Plan) performed a well-reasoned, high-integrity, and correct procurement process for third-party administrative services. This process clearly revealed that Aetna’s bid was superior to Blue Cross NC’s, and the Plan’s Board of Trustees properly approved the contract’s award to Aetna. As Judge Melissa Owens Lassiter said in her opinion:
(Raleigh, N.C.) Treasurer Dale R. Folwell, CPA, is calling today for the State Health Plan (Plan) Board of Trustees to end coverage of popular GLP-1 drugs like Wegovy and Saxenda for the purpose of weight loss until the drugs’ manufacturer, Danish multinational Novo Nordisk, prices the drugs fairly.
North Carolina State Treasurer Dale R. Folwell, CPA, released a report today that shows extreme variations in hospital prices, huge price markups from Medicare rates, and widespread failures in price transparency.
